{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:20:55Z","timestamp":1789399255013,"version":"build-2803163510"},"reference-count":50,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Since the late 1940s, mass vaccination programs in the USA have contributed to the significantly reduced morbidity and mortality of infectious diseases. To assist the evaluation of the benefits of mass vaccination programs, the number of individuals who would have suffered death or permanent disability in the USA in 2014, had mass vaccination never been implemented, was estimated for measles, mumps, rubella, tetanus, diphtheria, pertussis, polio, Haemophilus influenzae type b (Hib), hepatitis B, varicella, and human papillomavirus (HPV). The estimates accounted for mortality and morbidity trends observed for these infections prior to mass vaccination and the impact of advances in standard of living and health care. The estimates also considered populations with and without known factors leading to an elevated risk of permanent injury from infection. Mass vaccination prevented an estimated 20 million infections and 12,000 deaths and permanent disabilities in 2014, including 10,800 deaths and permanent disabilities in persons at elevated risk. Though 9000 of the estimated prevented deaths were from liver cirrhosis and cancer, mass vaccination programs have not, at this point, shown empirical impacts on the prevalence of those conditions. Future studies can refine these estimates, assess the impact of adjusting estimation assumptions, and consider additional risk factors that lead to heightened risk of permanent harm from infection.<\/jats:p>","DOI":"10.3390\/vaccines8040561","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T08:43:27Z","timestamp":1601369007000},"page":"561","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Measuring the Benefits of Mass Vaccination Programs in the United States"],"prefix":"10.3390","volume":"8","author":[{"given":"Hector","family":"Magno","sequence":"first","affiliation":[{"name":"Independent Computer Scientist, Orange County, CA 92677, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Golomb","sequence":"additional","affiliation":[{"name":"Department of Medicine, UC San Diego School of Medicine, La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"ref_1","unstructured":"(2016, December 10). Centers for Disease Control and Prevention, Available online: https:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/current-vis.html."},{"key":"ref_2","unstructured":"Hamborsky, J., Kroger, A., and Wolfe, S. (2015). Reported Cases and Deaths from Vaccine Preventable Diseases, United States, 1950\u20132013. Epidemiology and Prevention of Vaccine-Preventable Diseases, Public Health Foundation. [13th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1001\/jama.298.18.2155","article-title":"Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States","volume":"298","author":"Roush","year":"2007","journal-title":"J. Am. Med. Assoc."},{"key":"ref_4","unstructured":"(2014). Centers for Disease Control and Prevention. Benefits from Immunization During the Vaccines for Children Program Era\u2014United States, 1994\u20132013. Morb. Mortal. Wkly. Rep., 63, 352\u2013355."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1542\/peds.2013-0698","article-title":"Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009","volume":"133","author":"Zhou","year":"2014","journal-title":"Pediatrics"},{"key":"ref_6","unstructured":"Hamborsky, J., Kroger, A., and Wolfe, S. (2015). Rotavirus. Epidemiology and Prevention of Vaccine-Preventable Diseases, Public Health Foundation. [13th ed.]."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archinte.165.3.265","article-title":"Impact of influenza vaccination on seasonal mortality in the US elderly population","volume":"165","author":"Simonsen","year":"2005","journal-title":"Arch. Intern Med."},{"key":"ref_8","first-page":"1","article-title":"Vaccines for preventing influenza in healthy adults (Review)","volume":"3","author":"Demicheli","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/bmj.38995.531701.80","article-title":"Influenza vaccination: Policy versus evidence","volume":"333","author":"Jefferson","year":"2006","journal-title":"BMJ"},{"key":"ref_10","unstructured":"Hamborsky, J., Kroger, A., and Wolfe, S. (2015). Meningococcal Disease. Epidemiology and Prevention of Vaccine-Preventable Diseases, Public Health Foundation. [13th ed.]."},{"key":"ref_11","unstructured":"Centers for Disease Control and Prevention (2020, January 22). Active Bacterial Core Surveillance (ABCs) Report. Emerging Infections Program Network. Streptococcus pneumoniae, Available online: https:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/spneu00.pdf."},{"key":"ref_12","unstructured":"Centers for Disease Control and Prevention (2020, January 22). Active Bacterial Core Surveillance (ABCs) Report. Emerging Infections Program Network. Streptococcus pneumoniae, Available online: https:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/spneu09.pdf."},{"key":"ref_13","unstructured":"Centers for Disease Control and Prevention (2020, January 22). Wonder Database Search Query for Deaths from Pneumonia 2000\u20132009, Available online: https:\/\/wonder.cdc.gov\/ucd-icd10.html."},{"key":"ref_14","unstructured":"United States Department of Health, Education, and Welfare (1964). Table 1\u201323\u2014Deaths from 258 Selected Causes, by 5-Year Age Groups, Race, and Sex: United States, 1962. Vital Statistics of the United States 1962 Volume 2\u2014Mortality Part, A, United States Government Printing Office."},{"key":"ref_15","unstructured":"(2016, November 21). Infoplease Online Encyclopedia. Available online: https:\/\/www.infoplease.com\/us\/births\/live-births-and-birth-rates-year."},{"key":"ref_16","unstructured":"Hamilton, B.E., Martin, J.A., Osterman, M.J.K., Curtin, S.C., and Mathews, T.J. (2015). Births: Final Data for 2014. National Vital Statistics Reports, National Center for Health Statistics."},{"key":"ref_17","unstructured":"Hamborsky, J., Kroger, A., and Wolfe, S. (2015). Measles. Epidemiology and Prevention of Vaccine-Preventable Diseases, Public Health Foundation. [13th ed.]."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1086\/377712","article-title":"The clinical significance of measles: A review","volume":"189","author":"Perry","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJM199007193230304","article-title":"A randomized, controlled trial of vitamin A in children with severe measles","volume":"323","author":"Hussey","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_20","unstructured":"Center for Disease Control (1974). Mumps Surveillance, January 1972\u2013June 1974, CDC."},{"key":"ref_21","unstructured":"Hamborsky, J., Kroger, A., and Wolfe, S. (2015). Rubella. Epidemiology and Prevention of Vaccine-Preventable Diseases, Public Health Foundation. [13th ed.]."},{"key":"ref_22","unstructured":"National Communicable Disease Center (1969). Rubella Surveillance, June 1969, National Communicable Disease Center."},{"key":"ref_23","unstructured":"Hamborsky, J., Kroger, A., and Wolfe, S. (2015). Tetanus. Epidemiology and Prevention of Vaccine-Preventable Diseases, Public Health Foundation. [13th ed.]."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2105\/AJPH.30.3_Suppl.16","article-title":"Diphtheria Infection and Morbidity in Cleveland, 1937\u20131939","volume":"30","author":"Schuman","year":"1940","journal-title":"Am. J. Public Health"},{"key":"ref_25","unstructured":"United States Department of Health, Education, and Welfare (1968). Figure 18\u2014Death Rates for Diphtheria: Death-Registration States, 1900-32, and United States, 1933-60. Vital Statistics Rates in the United States 1940\u20131960, U.S. Government Printing Office."},{"key":"ref_26","unstructured":"United States Bureau of the Census (1975). Vital Statistics and Health and Medical Care. Historical Statistics of the United States, Colonial Times to 1970, Bicentennial Edition, Part 1; U.S. Government Printing Office."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2105\/AJPH.19.8.855","article-title":"The Factor of Chance in Diphtheria Mortality","volume":"19","author":"Lee","year":"1929","journal-title":"Am. J. Public Health Nation\u2019s Health"},{"key":"ref_28","unstructured":"Hamborsky, J., Kroger, A., and Wolfe, S. (2015). Diphtheria. Epidemiology and Prevention of Vaccine-Preventable Diseases, Public Health Foundation. [13th ed.]."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3177\/jnsv.22.313","article-title":"The Effects of Ascorbic Acid on Diphtheria Toxin and Intoxicated HeLa Cells","volume":"22","author":"Clark","year":"1976","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1128\/iai.59.6.1899-1904.1991","article-title":"Iron-Dependent Regulation of Diphtheria Toxin and Siderophore Expression by the Cloned Corynebacterium diphtheriae Repressor Gene dtxR in C. diphtheriae C7 Strains","volume":"59","author":"Schmitt","year":"1991","journal-title":"Infect. Immun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1128\/br.39.1.54-85.1975","article-title":"Diphtheria Toxin: Mode of Action and Structure","volume":"39","author":"Collier","year":"1975","journal-title":"Bacteriol. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3201\/eid0404.980404","article-title":"Diphtheria in the Former Soviet Union: Reemergence of a Pandemic Disease","volume":"4","author":"Vitek","year":"1998","journal-title":"Emerg. Infect. Dis."},{"key":"ref_33","unstructured":"Hamborsky, J., Kroger, A., and Wolfe, S. (2015). Pertussis. Epidemiology and Prevention of Vaccine-Preventable Diseases, Public Health Foundation. [13th ed.]."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00006454-198704000-00005","article-title":"Pertussis in Sweden after the cessation of general immunization in 1979","volume":"6","author":"Romanus","year":"1987","journal-title":"Pediatric Infect. Dis. J."},{"key":"ref_35","unstructured":"Atkinson, W., Wolfe, S., Hamborsky, J., and McIntyre, L. (2009). Poliomyelitis. Epidemiology and Prevention of Vaccine-Preventable Diseases, Public Health Foundation. [11th ed.]."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jama.1954.03690310001001","article-title":"Absence of Tonsils as a Factor in the Development of Bulbar Poliomyelitis","volume":"155","author":"Anderson","year":"1954","journal-title":"J. Am. Med Assoc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.1950.02910220016004","article-title":"Acute poliomyelitis: Relation of physical activity at the time of onset to the course of the disease","volume":"142","author":"Horstmann","year":"1950","journal-title":"J. Am. Med Assoc."},{"key":"ref_38","unstructured":"Hamborsky, J., Kroger, A., and Wolfe, S. (2015). Haemophilus Influenzae Type b. Epidemiology and Prevention of Vaccine-Preventable Diseases, Public Health Foundation. [13th ed.]."},{"key":"ref_39","unstructured":"Hamborsky, J., Kroger, A., and Wolfe, S. (2015). Hepatitis B. Epidemiology and Prevention of Vaccine-Preventable Diseases, Public Health Foundation. [13th ed.]."},{"key":"ref_40","unstructured":"Centers for Disease Control and Prevention (2016, October 29). Wonder Database Search Query for Deaths from Cirrhosis and Liver Cancer 2010\u20132014, Available online: https:\/\/wonder.cdc.gov\/ucd-icd10.html."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/315714","article-title":"Varicella mortality: Trends before vaccine licensure in the United States, 1970\u20131994","volume":"182","author":"Meyer","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_42","unstructured":"Centers for Disease Control and Prevention (2016, October 29). Wonder Database Search Query for Population Aged <1 Year, 1991\u20131994, Available online: https:\/\/wonder.cdc.gov\/Bridged-Race-v2015.HTML."},{"key":"ref_43","unstructured":"Hamborsky, J., Kroger, A., and Wolfe, S. (2015). Varicella. Epidemiology and Prevention of Vaccine-Preventable Diseases, Public Health Foundation. [13th ed.]."},{"key":"ref_44","unstructured":"Centers for Disease Control and Prevention (2018, August 07). Vaccine Information Statement: Live Zoster (Shingles) Vaccine ZVL What You Need Know 2018, Available online: https:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/vis-statements\/shingles.pdf."},{"key":"ref_45","unstructured":"Hamborsky, J., Kroger, A., and Wolfe, S. (2015). Human Papillomavirus. Epidemiology and Prevention of Vaccine-Preventable Diseases, Public Health Foundation. [13th ed.]."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"key":"ref_47","unstructured":"Centers for Disease Control and Prevention (2017, April 12). How Many Cancers Are Linked with HPV Each Year?, Available online: https:\/\/www.cdc.gov\/cancer\/hpv\/statistics\/cases.htm."},{"key":"ref_48","unstructured":"United States Department of Health, Education, and Welfare (1968). Death Rates for Detailed Causes: Death-Registration States, 1900\u20131932, and United States, 1933\u20131960. Vital Statistics Rates in the United States 1940\u20131960, U.S. Government Printing Office."},{"key":"ref_49","unstructured":"Centers for Disease Control and Prevention (2013). CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management. Morb. Mortal. Wkly. Rep., 62, 1\u201319."},{"key":"ref_50","unstructured":"(2017, May 26). National Cancer Institute, Available online: https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/infectious-agents\/hpv-vaccine-fact-sheet."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/4\/561\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:14:51Z","timestamp":1760177691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/4\/561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["vaccines8040561"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8040561","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]}}}